Morgan Stanley reiterated its overweight rating on Dalmia Bharat, while Macquarie advised an outperform rating for Axis Bank. Jefferies sustained a hold rating on Kotak Mahindra Bank, and Investec endorsed a buy rating for Aurobindo Pharma.
| Subscribe To Our Free Newsletter |
